Chime Financial slips 3.2% as investors digest annual filing and profitability outlook

Chime Financial, Inc. (CHYM) is down 3.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The decline looks consistent with investors continuing to weigh Chime’s recently filed annual report, which highlighted a sizable 2025 net loss alongside growing expenses tied to member activity and processing costs. Selling pressure may also be amplified by ongoing insider sales activity and general risk-off positioning in fintech after earlier volatility this year.

Details:

Chime filed its Form 10-K on March 6, 2026 for the year ended December 31, 2025, giving the market a fuller update on the company’s operating trends and risk factors.

The filing showed a 2025 net loss of about $1.01 billion (net loss per share of $4.27), which can heighten sensitivity to any signs of slowing growth or rising unit costs.

The annual report also described a board-authorized share repurchase program (up to $200 million), with $77.5 million repurchased in 2025 and $122.5 million remaining authorized as of year-end.

Insider transaction trackers show multiple insider sales in recent months, which can add incremental supply and weigh on sentiment even when pre-planned.

Sources:

SEC EDGAR, Chime Investor Relations, Insider Monkey

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHYM Insider Trading Activity

$CHYM insiders have traded $CHYM stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:

JAMES FEUILLE has made 0 purchases and 3 sales selling 183,397 shares for an estimated $4,957,755.
AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 2 sales selling 84,589 shares for an estimated $1,704,972.
CHRISTOPHER R BRITT (Chief Executive Officer) sold 50,000 shares for an estimated $1,402,825
ADAM B FRANKEL (General Counsel) has made 0 purchases and 6 sales selling 13,142 shares for an estimated $333,745.
MATTHEW S NEWCOMB (Chief Financial Officer) sold 10,000 shares for an estimated $280,109

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CHYM Hedge Fund Activity

We have seen 145 institutional investors add shares of $CHYM stock to their portfolio, and 103 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FORERUNNER VENTURES MANAGEMENT, LLC added 9,031,107 shares (+inf%) to their portfolio in Q4 2025, for an estimated $227,312,963
ASHTON THOMAS PRIVATE WEALTH, LLC added 5,128,770 shares (+inf%) to their portfolio in Q4 2025, for an estimated $129,091,140
CITADEL ADVISORS LLC added 4,249,643 shares (+178.3%) to their portfolio in Q4 2025, for an estimated $106,963,514
POINT72 ASSET MANAGEMENT, L.P. added 3,574,654 shares (+353.1%) to their portfolio in Q4 2025, for an estimated $89,974,041
ICONIQ CAPITAL, LLC removed 2,992,314 shares (-19.9%) from their portfolio in Q4 2025, for an estimated $75,316,543
IEQ CAPITAL, LLC added 2,312,846 shares (+inf%) to their portfolio in Q4 2025, for an estimated $58,214,333
GENERAL ATLANTIC, L.P. added 2,050,923 shares (+10.7%) to their portfolio in Q4 2025, for an estimated $51,621,731

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CHYM Analyst Ratings

Wall Street analysts have issued reports on $CHYM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Goldman Sachs issued a "Buy" rating on 01/06/2026
B. Riley Securities issued a "Buy" rating on 12/11/2025
JP Morgan issued a "Overweight" rating on 11/06/2025
Keefe, Bruyette & Woods issued a "Outperform" rating on 10/01/2025

To track analyst ratings and price targets for $CHYM, check out Quiver Quantitative's $CHYM forecast page.

$CHYM Price Targets

Multiple analysts have issued price targets for $CHYM recently. We have seen 11 analysts offer price targets for $CHYM in the last 6 months, with a median target of $30.0.

Here are some recent targets:

Alex Markgraff from Keybanc set a target price of $30.0 on 03/04/2026
Mark Mahaney from Evercore ISI Group set a target price of $35.0 on 02/26/2026
Timothy Chiodo from UBS set a target price of $27.0 on 02/26/2026
Harry Bartlett from Rothschild & Co set a target price of $29.0 on 01/26/2026
Will Nance from Goldman Sachs set a target price of $30.0 on 01/06/2026
Hal Goetsch from B. Riley Securities set a target price of $35.0 on 12/11/2025
Patrick Moley from Piper Sandler set a target price of $30.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.